Skip to main content
OpenTrials
Completed

NCT Number: NCT01118767

Evaluation of a Computer-Based System Using Cell Phones for HIV People in Peru

The investigators propose to develop and evaluate a computer-based intervention using cell phones to enhance adherence to antiretroviral treatment (ART) and support of HIV transmission risk-reduction among adult HIV-positive patients in Peru.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

HIV Acquired Immunodeficiency Syndrome Adherence Behavior Blood-Borne Infections Communicable Diseases Disease Attributes Genital Diseases HIV Infections Health Behavior Immune System Diseases Immunologic Deficiency Syndromes Infections Lentivirus Infections Medication Adherence Pathologic Processes Pathological Conditions, Signs and Symptoms Patient Acceptance of Health Care Patient Compliance Patient Satisfaction RNA Virus Infections Retroviridae Infections Sexual Behavior Sexually Transmitted Diseases Sexually Transmitted Diseases, Viral Slow Virus Diseases Treatment Adherence and Compliance Unsafe Sex Urogenital Diseases Virus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Universidad Peruana Cayetano Heredia, Lima, Peru

Loading trial locations.

About this study

Adherence to ART is critical for treatment success at the individual level and to avoid the onset of resistant strains of HIV. In Peru, where ART has recently been introduced, adherence to HIV treatment has not yet been addressed properly. Innovative approaches using information technologies such as cell phones are needed to increase adherence to ART for people with HIV/AIDS. The specific aims of the study are to: 1) Conduct formative research to assess culturally-specific behavioral messages to be included in the computer-based system; 2) Develop and test an interactive computer-based system using cell phones to enhance adherence to ART and to deliver HIV transmission risk reduction messages; 3) Evaluate the impact of the system on antiretroviral adherence and sexual risk behaviors.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • HIV-positive healthy male or female aged greater than or equal to 18
  • Currently on ART
  • Patients with a mobile phone for their personal use (not shared)
  • Patients who know how to retrieve read text messages on their mobile phone
  • Signed and dated written informed consent prior to admission to the study

Exclusion criteria

  • Patients whose clinical condition might have interfered with the study (e.g., deafness, serious mental illness, mental retardation)
  • Patients unable to give their informed consent.

Treatment and study plan

Cell phone intervention

Other

Participant receives short text messages, including: antiretroviral reminders, clinic appointment reminders, and preventive/educational messages

Primary outcomes

  1. Self-reported medication adherence

    Time frame: 12 months

  2. HIV-1 viral load

    Time frame: 12 months

Secondary outcomes

  1. CD4

    Time frame: 12 months

  2. Self-reported HIV transmission risk behaviors

    Time frame: 12 months

Sponsors and collaborators

Lead sponsor

Universidad Peruana Cayetano Heredia

Other

Collaborators

  • Fogarty International Center of the National Institute of Health

Registry information

Acronym: Cell-POS

Important dates

Study start
2010
Primary completion
2011
Study completion
2011
First posted
May 7, 2010
Registry last updated
Nov 22, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.